Dexcom Class Action Lawsuit 2026: Payouts and Updates

Never Miss a Lawsuit Update

Mark Lawfold as a Preferred Source so you never miss a settlement deadline or new filing.

The Dexcom class action lawsuit is gaining serious traction in 2026, with thousands of CGM users pursuing legal claims over faulty sensors, dangerous adhesive reactions, and inaccurate glucose readings. If you’ve used a Dexcom G6 or G7 and experienced problems, you may have a right to compensation.

This article breaks down everything happening with Dexcom litigation right now. You’ll find current case updates, settlement projections, payout estimates, and clear steps on how to file.

You might also find this useful — Clinique Advertising Dispute Model Lawsuit 2026 Updates

One detail that shocks most people: the FDA has received tens of thousands of adverse event reports linked to Dexcom devices. That number keeps climbing.

Whether you had a sensor fall off mid-sleep or got a dangerously wrong glucose reading, this guide covers your situation.

Dexcom Class Action Lawsuit 2026

The Dexcom class action lawsuit in 2026 involves claims that Dexcom Inc. sold defective continuous glucose monitors that caused physical harm and medical emergencies. Plaintiffs allege the company knew about device problems but failed to fix them or warn users properly.

These lawsuits target multiple Dexcom products, primarily the G6 and G7 sensor systems. The claims center on three main issues: adhesive injuries, sensor malfunctions, and inaccurate glucose readings that led to dangerous insulin dosing decisions.

Dexcom generated over $3.6 billion in revenue in 2024 alone. Critics argue the company prioritized growth over quality control.

The lawsuit pool includes both class action filings and individual personal injury cases. Some attorneys are pushing for MDL (multidistrict litigation) consolidation to streamline proceedings.

For people living with diabetes, a CGM isn’t optional. It’s a lifeline. When that lifeline gives bad data, the consequences can be severe.

Dexcom Lawsuit Update 2026

As of 2026, Dexcom lawsuits are progressing through both state and federal courts across the United States. Several new filings hit federal court dockets in early 2026, expanding the scope of claims against the company.

Key developments include growing pressure for MDL consolidation. Attorneys representing hundreds of plaintiffs have filed motions to centralize cases before a single federal judge. This would speed up discovery and pre-trial proceedings.

Dexcom has responded by filing motions to dismiss several individual cases. The company argues its devices meet FDA standards and that user error accounts for reported problems. Courts have denied most of those dismissal attempts so far.

• New federal filings in Q1 2026 added over 200 plaintiffs
• MDL consolidation motions are pending before the Judicial Panel on Multidistrict Litigation
• Bellwether trial selections could begin by late 2026
• Dexcom’s motions to dismiss have largely failed

Settlement talks are reportedly happening behind closed doors. Neither side has confirmed formal negotiations publicly, but legal insiders suggest early discussions are underway.

The pace of this litigation is faster than typical medical device cases. That’s partly because the evidence, including FDA reports and internal emails, is already well documented.

Dexcom Lawsuit Settlement

No official Dexcom lawsuit settlement has been finalized as of early 2026. The cases are still in active litigation, which means no global settlement agreement exists yet.

That said, legal experts expect settlement talks to intensify throughout 2026. Medical device companies often prefer settlements to the unpredictability of jury trials, especially when FDA complaint records make the evidence hard to dispute.

Think of it like a poker game. Dexcom is sitting across from thousands of plaintiffs who hold strong cards. Going to trial risks a massive verdict. Settling lets them control the damage.

When a settlement does happen, it will likely be tiered. Plaintiffs with documented medical injuries, like hospitalizations from wrong readings, would receive more than those with skin irritation alone.

Individual lawsuits with strong injury evidence could settle before a class-wide deal is reached. This is common in medical device litigation.

Anyone currently enrolled in the lawsuit should keep all medical records and device documentation organized. That evidence directly affects settlement value.

Key Takeaway: The Dexcom class action lawsuit is active in 2026 with growing case numbers, but no formal settlement has been announced yet; legal experts project resolution could begin in late 2026.

Dexcom Lawsuit Payout Amounts

Estimated Dexcom lawsuit payout amounts range from $5,000 to $250,000 or more per plaintiff, depending on injury type and severity. These projections come from legal analysts comparing similar medical device settlements.

No official payout schedule exists yet because the case hasn’t settled. But looking at past CGM and medical device cases gives a solid baseline for expectations.

These numbers are educated estimates, not guarantees. The actual amounts will depend on what Dexcom agrees to pay or what a jury awards.

Factors that increase your payout include:

• Medical records showing direct harm from the device
• Proof of hospitalization
• Evidence of long-term complications
• Documentation that Dexcom was contacted about the problem
• Receipts or insurance records showing which device you used

People with mild skin reactions will likely receive less than those who ended up in an emergency room because their sensor showed normal glucose while they were actually experiencing severe hypoglycemia.

The severity of your injury is the single biggest factor in what you’ll receive.

Who Qualifies for the Dexcom Lawsuit

You may qualify for the Dexcom lawsuit if you used a Dexcom G6 or G7 CGM system and experienced a device malfunction, adhesive injury, or inaccurate reading that caused harm. Eligibility is broad, covering users across the United States.

Here are the primary eligibility criteria:

• You used a Dexcom G6 or G7 continuous glucose monitor
• You experienced at least one documented issue (sensor failure, adhesive reaction, false reading)
• The device problem caused you physical harm, medical emergency, or financial loss
• You have medical records, purchase receipts, or insurance claims as proof
• The issue occurred within the applicable statute of limitations (varies by state)

You don’t need to have filed an FDA report to qualify. But having done so adds weight to your claim.

Even if your injury seems minor, like persistent skin irritation at the sensor site, you may still be eligible. The key question is whether the device caused you harm that Dexcom should have prevented.

Dexcom G6 Lawsuit

The Dexcom G6 lawsuit focuses on widespread reports of sensor failures, adhesive chemical burns, and inaccurate glucose readings from the G6 CGM system. The G6 has been on the market since 2018, and complaints started piling up within the first year.

The G6 was marketed as a breakthrough: no fingerstick calibration needed. But that selling point became a liability. Users trusted the device’s readings completely. When those readings were wrong, people made dangerous insulin dosing decisions without a backup check.

Specific G6 complaints include:

• Sensors detaching before the 10-day wear period ended
• Readings that showed stable glucose during actual hypoglycemic events
• Adhesive causing contact dermatitis, blistering, or chemical burns
• Transmitter connection failures causing data gaps
• Error messages that left users without glucose data for hours

The adhesive used in G6 sensors contains isoborynl acrylate, known as IBOA. This chemical is a known skin sensitizer. Repeated exposure can cause progressively worse allergic reactions.

Court filings show that Dexcom received thousands of complaints about IBOA-related skin injuries but continued using the same adhesive formulation for years.

The G6 represents the largest share of current Dexcom litigation. More plaintiffs have filed over G6 problems than any other Dexcom product.

Dexcom G7 Lawsuit

The Dexcom G7 lawsuit targets the company’s newest CGM sensor, which launched in the U.S. in 2023. Despite being marketed as an improved version of the G6, many of the same problems persisted.

G7 users report similar issues: sensors that fall off early, inaccurate readings during critical glucose events, and skin reactions at the application site. Some users say the G7 actually performs worse than the G6 in certain conditions.

The shorter warm-up time on the G7 was supposed to be a major improvement. But complaints suggest the G7’s accuracy during that critical first few hours is unreliable.

Some plaintiffs allege that Dexcom rushed the G7 to market to compete with Abbott’s FreeStyle Libre 3. Speed-to-market pressure, they argue, came at the expense of thorough quality testing.

G7 lawsuits are newer but growing fast. Attorneys expect them to be folded into the same litigation framework as G6 cases since the core allegations are nearly identical.

Key Takeaway: Both the Dexcom G6 and G7 face lawsuits for similar defects, and eligibility is broad enough to include most users who experienced device problems, skin injuries, or inaccurate readings.

Dexcom Adhesive Lawsuit

The Dexcom adhesive lawsuit centers on claims that the adhesive used to attach CGM sensors to the skin contains chemicals that cause allergic reactions, contact dermatitis, blistering, and chemical burns. The primary chemical under scrutiny is isoborynl acrylate, or IBOA.

IBOA is a known skin sensitizer recognized by dermatological research organizations worldwide. Once a person becomes sensitized to it, every subsequent exposure triggers a worse reaction. Think of it like poison ivy: the first exposure might cause mild irritation, but the tenth exposure can be severe.

Plaintiffs report injuries ranging from mild redness to open wounds requiring medical treatment. Some users developed permanent scarring at sensor application sites.

• Red, raised welts matching the exact shape of the sensor patch
• Fluid-filled blisters that burst and left raw skin
• Dark pigmentation changes lasting months after sensor removal
• Infections from open wounds caused by adhesive reactions
• Need for prescription-strength topical steroids to manage symptoms

What makes these claims particularly strong is that alternative adhesive formulations exist. Competitors have moved away from IBOA-based adhesives. Plaintiffs argue Dexcom chose the cheaper option over the safer one.

Court documents reveal internal communications where Dexcom employees discussed adhesive complaints. The company reportedly explored reformulation but delayed implementation, according to filings.

Dexcom Sensor Malfunction Lawsuit

The Dexcom sensor malfunction lawsuit addresses claims that CGM sensors frequently fail before their intended lifespan, leaving users without critical glucose data. A sensor that dies early isn’t just an inconvenience; it’s a safety hazard.

Dexcom sensors are designed to last 10 days. Plaintiffs report sensors failing after just 2 to 5 days with no warning. When a sensor fails, the user loses real-time glucose monitoring until a replacement is inserted and warmed up.

For someone on an insulin pump that auto-adjusts based on CGM data, a sudden sensor failure can mean hours without proper insulin delivery management.

Common malfunction types include:

Readers also liked: NFL Lawsuit Kelly and Sons 2026: Settlement and Payouts

• Premature sensor expiration errors
• “Sensor error” messages with no explanation
• Signal loss between sensor and transmitter
• Readings freezing on a single number for extended periods
• Complete sensor failure within 48 hours of application

Dexcom offers free replacement sensors for malfunctions. But plaintiffs argue that replacement policies don’t address the safety risk during the gap between failure and replacement.

The lawsuit alleges Dexcom knew about high failure rates from internal quality data but continued selling sensors without adequate warnings or design fixes.

Dexcom False Readings Lawsuit

The Dexcom false readings lawsuit is one of the most serious threads in this litigation because inaccurate glucose data can directly cause medical emergencies. When a CGM tells you your blood sugar is 120 mg/dL but it’s actually 45 mg/dL, the results can be life-threatening.

Plaintiffs allege that Dexcom CGMs produce dangerously inaccurate readings in certain conditions. These include the first 24 hours after sensor insertion, during rapid glucose changes, and when the sensor is compressed during sleep.

“Compression lows” are a well-known issue. When you sleep on the arm wearing the sensor, pressure can cause the device to report falsely low glucose numbers. Users then eat unnecessary carbohydrates to treat a low that doesn’t exist, causing actual hyperglycemia.

The opposite scenario is even more dangerous. A sensor reading “normal” when glucose is actually dangerously low can lead to:

• Delayed treatment for severe hypoglycemia
• Loss of consciousness
• Seizures
• Hospitalization
• In rare cases, death

Dexcom markets its CGMs as accurate enough to make insulin dosing decisions without fingerstick confirmation. Plaintiffs argue this marketing claim is misleading given the documented accuracy problems.

FDA MAUDE data contains thousands of reports describing false readings. Many include descriptions of emergency room visits directly linked to CGM inaccuracy.

Key Takeaway: Dexcom’s adhesive ingredients, sensor reliability failures, and false glucose readings form the three strongest pillars of current litigation, with false readings posing the most immediate danger to users.

Dexcom Recall Lawsuit

The Dexcom recall lawsuit connects to multiple product recalls the company has issued, arguing that Dexcom knew about defects before selling affected devices and delayed recalls to protect revenue.

Dexcom has issued several recalls over the years. The most notable ones include:

The FDA classifies medical device recalls by severity. Several Dexcom recalls have been classified as Class I, which the FDA defines as situations where there is a reasonable probability that use of the product will cause serious health consequences or death.

A Class I recall is the most serious type. It means the FDA determined real danger existed.

Plaintiffs in recall-related lawsuits argue Dexcom had internal quality control data showing defects before the devices shipped. They claim the company chose to sell the products anyway and only initiated recalls after complaints became impossible to ignore.

These recall lawsuits often overlap with sensor malfunction and false readings claims. If your specific device was part of a recall, your legal position is stronger.

Dexcom FDA Complaints

Dexcom FDA complaints number in the tens of thousands, documented in the FDA’s MAUDE (Manufacturer and User Facility Device Experience) database. Each report represents a real person who experienced a problem serious enough to report to a federal agency.

The MAUDE database is publicly searchable. Anyone can look up Dexcom adverse event reports. The volume of complaints is staggering compared to similar devices from competitors.

Common categories of FDA complaints against Dexcom include:

• Device produces inaccurate glucose values
• Sensor adhesive causes skin injury
• Sensor falls off before intended wear period
• Device fails to alert user to dangerous glucose levels
• Sensor wire breaks off under the skin

FDA complaints matter in litigation because they create an official paper trail. Every report filed with the FDA is a piece of evidence that Dexcom was on notice about device problems.

If you filed an FDA complaint about your Dexcom device, keep the confirmation number. That report directly supports your lawsuit claim.

Attorneys are using MAUDE data to establish that Dexcom had actual knowledge of defects and failed to take adequate corrective action. The sheer volume of reports makes a “we didn’t know” defense very difficult for Dexcom to sustain.

Dexcom CGM Injury Claims

Dexcom CGM injury claims cover the full range of physical harm caused by defective continuous glucose monitors, from skin reactions to emergency hospitalizations. These claims form the core of both individual lawsuits and the broader class action.

Injuries documented in court filings fall into two main categories: direct physical injuries from the device itself and indirect injuries caused by device failures leading to wrong medical decisions.

Direct physical injuries:

• Contact dermatitis and allergic reactions from adhesive
• Second-degree chemical burns at sensor sites
• Permanent skin discoloration or scarring
• Infections from wounds caused by adhesive reactions
• Retained sensor wire fragments under the skin requiring surgical removal

Indirect injuries from device failure:

• Severe hypoglycemia requiring emergency treatment
• Diabetic ketoacidosis from undetected hyperglycemia
• Seizures caused by undetected low blood sugar
• Falls or accidents during hypoglycemic episodes
• Psychological trauma from loss of trust in glucose monitoring

The strongest claims combine physical evidence with clear causation. A medical record showing you went to the ER because your Dexcom showed normal glucose during a severe low is powerful evidence.

Key Takeaway: Dexcom injury claims span from adhesive burns documented in thousands of FDA reports to life-threatening emergencies caused by false readings, with the strongest cases involving hospitalization records tied directly to device failure.

Dexcom Product Liability

Dexcom product liability claims are built on three legal theories: manufacturing defect, design defect, and failure to warn. Each theory attacks a different aspect of how Dexcom brought its CGMs to market.

A manufacturing defect means something went wrong during production. Specific batches of sensors didn’t meet quality standards. This explains why some users have perfect experiences while others get sensors that fail on day one.

A design defect means the product’s fundamental design is flawed. The choice to use IBOA adhesive is a design defect argument. No matter how perfectly the sensor is manufactured, the adhesive itself causes harm.

Failure to warn means Dexcom didn’t adequately tell users about known risks. If the company knew sensors could give dangerously wrong readings in certain conditions but didn’t clearly communicate that, it’s a failure to warn.

Under product liability law, Dexcom doesn’t need to have acted intentionally. The company just needs to have sold a product that was unreasonably dangerous. Plaintiffs don’t have to prove Dexcom wanted to hurt anyone.

Strict liability applies in most states. This means plaintiffs only need to show the product was defective and caused harm. They don’t need to prove negligence.

This legal framework is favorable for Dexcom plaintiffs because the evidence of defects is well documented through FDA reports, recall records, and internal company communications.

How to File a Dexcom Lawsuit Claim

Filing a Dexcom lawsuit claim starts with contacting an attorney who handles medical device litigation. Most firms offering representation in Dexcom cases work on contingency, meaning you pay nothing upfront and they take a percentage only if you win.

Here’s a step-by-step breakdown:

Step 1: Gather your evidence.

• Collect medical records showing Dexcom-related injuries or ER visits
• Save photos of skin reactions or adhesive burns
• Find purchase receipts or insurance claims for Dexcom products
• Note the device model, serial number, and lot number if available
• Pull any FDA complaints you may have filed

Step 2: Contact a qualified attorney.

Look for law firms with specific experience in medical device lawsuits. Ask about their track record with CGM or diabetes device cases.

Step 3: Initial case review.

The attorney will evaluate your situation during a free consultation. They’ll determine which legal theories apply to your case and estimate its potential value.

For more context, see Business Lawsuit Israel 2026: Full Filing and Payout Guide

Step 4: Filing the claim.

Your attorney files the complaint in the appropriate court. This may be state or federal court depending on your location and the case strategy.

Step 5: Discovery and litigation.

After filing, both sides exchange evidence. This process can take months. Your case may be consolidated with others in MDL proceedings.

The process is simpler than most people think. Your attorney handles the legal complexity. Your main job is providing documentation.

Dexcom Lawsuit Deadline 2026

The Dexcom lawsuit deadline depends on your state’s statute of limitations for product liability and personal injury claims. Most states give you 2 to 4 years from the date of injury or from when you discovered the injury to file.

This is a critical point. The clock doesn’t always start on the day you were hurt. In many states, the “discovery rule” applies. That means the deadline starts when you knew or should have known that Dexcom’s device caused your harm.

If you’re reading this in 2026, time may be running out for injuries that occurred in 2022, 2023, or 2024. Don’t assume you have unlimited time.

Missing the deadline means losing your right to sue entirely. Courts enforce statutes of limitations strictly. Even one day late can kill your case.

The safest approach is to contact an attorney now. Even if you’re unsure whether your situation qualifies, a free case review costs you nothing and protects your rights before the window closes.

Key Takeaway: Most states allow 2 to 4 years to file a Dexcom lawsuit from the date of injury or discovery, but deadlines in 2026 may already be closing for users hurt in earlier years, making immediate action essential.

Dexcom Class Action Settlement Amount

The projected Dexcom class action settlement amount could reach hundreds of millions of dollars if the case resolves similarly to other major medical device settlements. Individual payouts will vary widely based on injury severity.

For perspective, here’s how other medical device settlements compare:

Dexcom’s case differs from joint replacement or implant cases because many injuries are less physically severe. But the massive number of affected users compensates for lower individual claim values. When millions of people used a defective product, even moderate per-person payouts add up to enormous total settlements.

A realistic range for the total Dexcom settlement sits between $100 million and $500 million, based on current plaintiff counts and injury profiles. That’s a wide range because much depends on how many plaintiffs ultimately join and what evidence emerges during discovery.

If Dexcom loses a bellwether trial badly, the settlement amount will spike. Companies pay more when a jury verdict shows them what they’ll face at trial. If early trials favor Dexcom, settlement leverage shifts.

The timing of payouts after settlement approval typically runs 6 to 12 months. Courts need time to process claims, verify eligibility, and distribute funds.

Frequently Asked Questions

Is there a class action lawsuit against Dexcom in 2026?

Yes, multiple class action and individual lawsuits are active against Dexcom in 2026.

Cases involve claims about defective sensors, dangerous adhesive ingredients, and inaccurate glucose readings.

Attorneys are seeking MDL consolidation to streamline the litigation process.

How much money can I get from the Dexcom lawsuit?

Estimated individual payouts range from $5,000 to $250,000 depending on your injury.

More severe injuries involving hospitalization or surgery receive higher compensation.

Final amounts won’t be confirmed until a settlement is approved or jury verdicts are issued.

What are the most common complaints in Dexcom lawsuits?

The three most common complaints are adhesive skin injuries, premature sensor failures, and dangerously inaccurate glucose readings.

Adhesive reactions caused by the chemical IBOA represent the largest category of physical harm claims.

False readings that led to wrong insulin doses and medical emergencies are the most legally significant complaints.

What is the deadline to file a Dexcom lawsuit claim?

Deadlines vary by state, with most statutes of limitations ranging from 2 to 4 years from the date of injury.

The discovery rule may extend this deadline if you only recently learned the device caused your harm.

Contact an attorney immediately to confirm your specific filing deadline before it expires.

Does the Dexcom lawsuit cover both G6 and G7 devices?

Yes, the Dexcom lawsuit covers both the G6 and G7 CGM systems.

Both devices share similar defect allegations including adhesive problems and sensor inaccuracy.

G6 cases currently outnumber G7 cases, but G7 filings are increasing rapidly as more users report issues.

This lawsuit isn’t going away. If anything, it’s picking up speed as more Dexcom users come forward with evidence of device failures and injuries.

Check whether your device, your injury, and your timeline fit the eligibility criteria. The window to act is open right now, but statutes of limitations don’t wait.

Gather your records, reach out to a medical device attorney, and protect your right to compensation before your state’s deadline passes.

Don't miss this — Young Durham Real Estate Lawsuit 2026: Full Claim Guide

Never Miss a Lawsuit Update

Mark Lawfold as a Preferred Source so you never miss a settlement deadline or new filing.